These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 20050759
1. The platelet functions in patients with ankylosing spondylitis: anti-TNF-alpha therapy decreases the mean platelet volume and platelet mass. Yazici S, Yazici M, Erer B, Erer B, Calik Y, Bulur S, Ozhan H, Ataoglu S. Platelets; 2010; 21(2):126-31. PubMed ID: 20050759 [Abstract] [Full Text] [Related]
2. The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Yazici S, Yazici M, Erer B, Erer B, Calik Y, Ozhan H, Ataoglu S. Platelets; 2010; 21(2):122-5. PubMed ID: 20050760 [Abstract] [Full Text] [Related]
3. Lifestyle modification decreases the mean platelet volume in prehypertensive patients. Yazici M, Kaya A, Kaya Y, Albayrak S, Cinemre H, Ozhan H. Platelets; 2009 Feb; 20(1):58-63. PubMed ID: 19172523 [Abstract] [Full Text] [Related]
10. Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab. Spanakis E, Sidiropoulos P, Papadakis J, Ganotakis E, Katsikas G, Karvounaris S, Bizaki A, Kritikos H, Boumpas DT. J Rheumatol; 2006 Dec; 33(12):2440-6. PubMed ID: 17014005 [Abstract] [Full Text] [Related]
11. Evaluation of circulating endothelial and platelet microparticles in men with ankylosing spondylitis. Sari I, Bozkaya G, Kirbiyik H, Alacacioglu A, Ates H, Sop G, Can G, Taylan A, Piskin O, Yildiz Y, Akkoc N. J Rheumatol; 2012 Mar; 39(3):594-9. PubMed ID: 22247348 [Abstract] [Full Text] [Related]
12. Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry. Glintborg B, Ostergaard M, Krogh NS, Dreyer L, Kristensen HL, Hetland ML. Ann Rheum Dis; 2010 Nov; 69(11):2002-8. PubMed ID: 20511613 [Abstract] [Full Text] [Related]
19. Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response. Braun J, Baraliakos X, Listing J, Fritz C, Alten R, Burmester G, Krause A, Schewe S, Schneider M, Sörensen H, Zeidler H, Sieper J. Ann Rheum Dis; 2008 Mar; 67(3):340-5. PubMed ID: 17967831 [Abstract] [Full Text] [Related]
20. Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept. Woo JH, Lee HJ, Sung IH, Kim TH. J Rheumatol; 2007 Aug; 34(8):1753-9. PubMed ID: 17610317 [Abstract] [Full Text] [Related] Page: [Next] [New Search]